retinoblastomamelphalantopotecanTPTTPT-related
… and topotecan (TPT) has shown its efficacy in the treatment of retinoblastoma over the last few years. Due to rapid hydrolysis, melphalan mus…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 390 of 2459spironolactonefamciclovirMSTherapeutics Goods AdministrationAustralian and New Zealand Clinical Trial Registryprogressive multiple sclerosis
…age, randomised, double-blind, placebo-controlled trial testing spironolactone and famciclovir to prevent disability progression in MS. Austra…
cancerNTM pulmonary diseasechronic obstructive pulmonary diseasemacrolidesInhaled corticosteroidsCOPDNTM lung disease
…low body weight, AAT deficiency, inhaled corticosteroid use and cancer.…
cancerShort Form 36 Health SurveyHospital Anxiety and Depression Scalesolid tumourstertiary care centrespiritual care
…ysical symptoms severity—and pave the way to potentially modify cancer treatment protocols in the Middle East.…
la/mUCRAIchemotherapy-naïvelocally advanced or metastatic urothelial carcinomachemotherapy-experiencedurology departments
…therapy-naïve.Conclusions In this study, Japanese patients with la/mUC were more concerned about reduced quality of life due to advers…
hypertensionbisoprololamlodipineirbesartanindapamidecandesartanQUARTETquadpill
…fective in reducing blood pressure (BP) among participants with hypertension. By pooling these trials, we can estimate the overall benefit o…
heart failureNICETriageHF PlusUK National Institute of Health and Care ExcellenceTriageHF PlusHFNCT04177199
…geHF alerts as an option for remote monitoring of patients with heart failure (HF) and a compatible cardiac implantable electronic device (CI…
TBtuberculosisCENTRALWHO Library DatabaseMEDLINEEMBASE
…are providers, both public and private, to deliver high-quality TB diagnosis and treatment.Design Systematic review without meta-a…
CyclosporineUveitisScience Direct
… severe ocular complications and vision loss if left untreated. Cyclosporine has gained recognition as an effective immunosuppressive therap…
asthma
…nd sensitive tool for objective remote monitoring of paediatric asthma.Methods Observational study of school-aged healthy, well-contro…
heart failurecirrhosiscancerMASLDKorean National Health Insurance Service
…Fs. Therefore, MASLD’s role may warrant consideration in future heart failure risk stratification.…
tirofibanischemic strokeatherosclerotic stenosisaspirinclopidogrel
… post-procedure.Results 150 patients were included: 72 received tirofiban and 78 received dual antiplatelets. AST occurred in 2.8% of the…